drugset / Trial / NCT05655676
89Zr-labeled NY008 PET Imaging in Patients
NaSingle-groupOpen-labelDiagnostic
Summary
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY008 PET Imaging in patients with multiple myeloma
Timeline
- Start
- 2022-05-25
- Primary completion
- 2023-05
- Completion
- 2023-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 89Zr-NY008 | Unknown | 2 mbq | — |
| Subject | 89Zr-NY008 | Unknown | 3 mbq | — |
| Subject | 89Zr-NY008 | Unknown | 5 mg | — |
| Subject | 89Zr-NY008 | Unknown | 10 mg | — |